HealthMesothelioma

Mesothelioma Clinical Trial – Do Your Genes Put You at Risk?

As a mesothelioma patient, you know all too well the frustration that persists over the helplessness and many unknown factors that surround the disease.  But what if as a mesothelioma patient you could join other mesothelioma patients all across the United States in accomplishing something significant in the fight against mesothelioma?  What if you could contribute to scientific knowledge through a mesothelioma clinical trial that could help prevent someone else from becoming a mesothelioma patient in the future?

Well, now you can.  And if the names Sloan Kettering, Mayo Clinic and Johns Hopkins ring a bell, you’ll realize that as a mesothelioma patient, you will be in very good hands. These are several of the major medical institutions involved in a new research study on genetics and mesothelioma. In order to move forward, this study needs volunteers who are mesothelioma patients just like you. In fact, 1000 of you are needed for the results to be meaningful.

If you do consider volunteering, please be sure to refer to this study by its ClinicalTrials.gov identifier: NCT01590472

Do Your Genes Put You at a Higher Risk of Developing Mesothelioma? –  Clinical Trial Details

  • First received  – April 23, 2012
  • Last updated  – November 4, 2013
  • Sponsor  – Wake Forest School of Medicine
  • Collaborators  – University of Pennsylvania, Mayo Clinic, New York University School of Medicine, Johns Hopkins University, Memorial Sloan-Kettering Cancer Center
  • Purpose – The researchers hope to find out whether a genetic component can help determine who is most susceptible to developing mesothelioma from asbestos exposure.
  • Discussion of outcome measures – Participants will be seen one time lasting 30-60 minutes to give a blood sample and basic factual information
  • Estimated Enrollment – 1000 mesothelioma patients
  • Study Start Date –  June 2011 (but recruiting volunteers now)
  • Estimated Study Completion Date – December 2015
  • Estimated Primary Completion Date – December 2014
  • Eligibility –  Over age 18 and diagnosed with mesothelioma
  • Contacts –
Johns Hopkins University
Baltimore, Maryland, United States,
Principal Investigator: Julie R Brahmer, MD
Mayo Clinic
Rochester, Minnesota, United States
Principal Investigator: Tobias Peikert, MD
New York University School of Medicine
New York, New York, United States
Principal Investigator: Harvey I Pass, MD
Memorial Sloan Kettering Cancer Center
New York, New York, United States
Principal Investigator: Lee Krug, MD
Wake Forest University Health Sciences
Winston-Salem, North Carolina, United States
Principal Investigator: Jill Ohar, MD
University of Pennsylvania
Philadelphia, Pennsylvania, United States
Principal Investigator: Daniel H Sterman, MD

 

 

Tags
Show More

Amir Hussain

Amir Hussain is the founder of Freemium World, a geek by nature and a professional Blog writer . I love to write about new technology trends, social media, hacking, blogging and much more.

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button
Close